Targeting STAT3 Enzyme for Cancer Treatment

被引:0
|
作者
Arun, Sowmiya [1 ]
Patel, Praveen Kumar [1 ]
Lakshmanan, Kaviarasan [2 ]
Rajangopal, Kalirajan [1 ]
Swaminathan, Gomathi [1 ]
Byran, Gowramma [1 ]
机构
[1] JSS Acad Higher Educ & Res, Dept Pharmaceut Chem, JSS Coll Pharm, Nilgiris 643001, Tamil Nadu, India
[2] Satyabhama Inst Sci & Technol, Sch Pharm, Dept Pharmaceut Chem, Chennai, Tamil Nadu, India
关键词
STAT3; inhibitors; SH-2; domain; proliferation; phosphorylation; hematological malignancies; tyrosine residue; NF-KAPPA-B; SIGNAL TRANSDUCER; TRANSCRIPTION; 3; KEY REGULATOR; EXPRESSION; ACTIVATOR; COMMUNICATION; SUPPRESSOR; APOPTOSIS; REVEALS;
D O I
10.2174/0113895575254012231024062619
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A category of cytoplasmic transcription factors called STATs mediates intracellular signaling, which is frequently generated at receptors on cell surfaces and subsequently sent to the nucleus. STAT3 is a member of a responsible for a variety of human tumor forms, including lymphomas, hematological malignancies, leukemias, multiple myeloma and several solid tumor types. Numerous investigations have demonstrated constitutive STAT3 activation lead to cancer development such as breast, head and neck, lung, colorectal, ovarian, gastric, hepatocellular, and prostate cancers. It's possible to get a hold of the book here. Tumor cells undergo apoptosis when STAT3 activation is suppressed. This review highlights the STAT3 activation and inhibition which can be used for further studies.
引用
收藏
页码:1252 / 1261
页数:10
相关论文
共 50 条
  • [11] Targeting the transcriptional activity of STAT3 by a novel fusion protein
    Chen, Yanqiong
    Zhang, Wenting
    Bai, Xiufeng
    Liu, Yi
    BMC CANCER, 2022, 22 (01)
  • [12] Ursolic Acid Inhibits the Growth of Colon Cancer-initiating Cells by Targeting STAT3
    Wang, Wenlong
    Zhao, Chongqiang
    Jou, David
    Lu, Jiagao
    Zhang, Cuntai
    Lin, Li
    Lin, Jiayuh
    ANTICANCER RESEARCH, 2013, 33 (10) : 4279 - 4284
  • [13] STAT3 regulates glycolysis via targeting hexokinase 2 in hepatocellular carcinoma cells
    Li, Man
    Jin, Rui
    Wang, Weihua
    Zhang, Tieying
    Sang, Jiao
    Li, Na
    Han, Qunying
    Zhao, Wenxuan
    Li, Chunyan
    Liu, Zhengwen
    ONCOTARGET, 2017, 8 (15) : 24777 - 24784
  • [14] Novel activators and small-molecule inhibitors of STAT3 in cancer
    Yang, Lehe
    Lin, Shichong
    Xu, Lingyuan
    Lin, Jiayuh
    Zhao, Chengguang
    Huang, Xiaoying
    CYTOKINE & GROWTH FACTOR REVIEWS, 2019, 49 : 10 - 22
  • [15] Targeting key transcriptional factor STAT3 in colorectal cancer
    Chalikonda, Gayathri
    Lee, Hoomin
    Sheik, Aliya
    Huh, Yun Suk
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2021, 476 (09) : 3219 - 3228
  • [16] Trichothecin Inhibits Cancer-Related Features in Colorectal Cancer Development by Targeting STAT3
    Qi, Xin
    Li, Meng
    Zhang, Xiao-min
    Dai, Xiu-fen
    Cui, Jian
    Li, De-hai
    Gu, Qian-qun
    Lv, Zhi-hua
    Li, Jing
    MOLECULES, 2020, 25 (10):
  • [17] Eriocalyxin B Inhibits STAT3 Signaling by Covalently Targeting STAT3 and Blocking Phosphorylation and Activation of STAT3
    Yu, Xiaokui
    He, Li
    Cao, Peng
    Yu, Qiang
    PLOS ONE, 2015, 10 (05):
  • [18] Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1
    Su, Jung-Chen
    Chang, Chuan-Hsun
    Wu, Szu-Hsien
    Shiau, Chung-Wai
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2018, 33 (01) : 1248 - 1255
  • [19] Lycorine Displays Potent Antitumor Efficacy in Colon Carcinoma by Targeting STAT3
    Wu, Song
    Qiu, Yuling
    Shao, Yingying
    Yin, Shuangshuang
    Wang, Rui
    Pang, Xu
    Ma, Junhong
    Zhang, Chunze
    Wu, Bo
    Koo, Sangho
    Han, Lifeng
    Zhang, Yi
    Gao, Xiumei
    Wang, Tao
    Yu, Haiyang
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [20] Targeting STAT3 and NF-κB Signaling Pathways in Cancer Prevention and Treatment: The Role of Chalcones
    Krajka-Kuzniak, Violetta
    Belka, Marta
    Papierska, Katarzyna
    CANCERS, 2024, 16 (06)